Emilysato (@emilysatomed) 's Twitter Profile
Emilysato

@emilysatomed

ID: 949042461829050368

calendar_today04-01-2018 22:18:50

5 Tweet

8 Followers

370 Following

Emilysato (@emilysatomed) 's Twitter Profile Photo

I am so happy to learn that our paper has been published. Big thanks to the best mentor Gilmara Coelho Meine MD, MSc and our amazing team . #MedTwitter #IMG #Gastroenterology

Gilmara Coelho Meine MD, MSc (@gilmarameine) 's Twitter Profile Photo

Efficacy and safety of FGF21 analogues for metabolic dysfunction-associated steatohepatitis In Annals of Nutrition and Metabolism 👉 pubmed.ncbi.nlm.nih.gov/39362207/ #GITwitter #MedTwitter #Feevale @Samira67964520 Emilysato

Efficacy and safety of FGF21 analogues for metabolic dysfunction-associated steatohepatitis 
In Annals of Nutrition and Metabolism
👉 pubmed.ncbi.nlm.nih.gov/39362207/

#GITwitter #MedTwitter #Feevale 
@Samira67964520  <a href="/Emilysatomed/">Emilysato</a>
Emilysato (@emilysatomed) 's Twitter Profile Photo

Hey #MedTwitter! 👩‍⚕️ I'm an IMG from Brazil living in Florida, preparing for my USMLE exams and eager to dive into research! 🩺Any leads, advice, or connections would mean the world! 🙌 #MedEd #IMG #Research #Internalmedicine

Samira Mohamad (@samiramkhalil) 's Twitter Profile Photo

New study in Clinics and Research in Hepatology and Gastroenterology! We evaluated the efficacy and safety of Aldafermin (FGF-19 analogue) in MASH, analyzing subgroups based on fibrosis stage and Aldafermin dosage. 💊 Link: authors.elsevier.com/c/1ksBH7sgWBrs…

New study in Clinics and Research in Hepatology and Gastroenterology!

We evaluated the efficacy and safety of Aldafermin (FGF-19 analogue) in MASH, analyzing subgroups based on fibrosis stage and Aldafermin dosage. 💊

Link: authors.elsevier.com/c/1ksBH7sgWBrs…